Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

Overview of attention for article published in Cancer Cell International, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 4 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

Cancer Cell International, 30 Dec 2022

Abstract Background The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its homeostatic action on certain…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.